Advertisement

Boston Scientific CEO Michael Mahoney tells investors that the new 2.3% medical device sales tax will cost the company about $75 million in 2013.

Boston Scientific logo

Medtech giant Boston Scientific (NYSE:BSX) estimates that its 2013 medical device tax obligation will amount to around $75 million, president & CEO Michael Mahoney told an audience the company's analyst meeting in New York today.

The Massachusetts-based medical device company aims to overcome that hurdle along with slow growth in some of its key businesses, hoping to post 2013 growth that out-paces the rest of the market.

Advertisement
Advertisement